Business · 16/10/20261 min read

Sobi receives positive CHMP opinion for TRYNGOLZA® (olezarsen) for the treatment of severe hypertriglyceridemia (sHTG)

Summary

Sobi has received a positive opinion from the CHMP for its treatment TRYNGOLZA® (olezarsen) for severe hypertriglyceridemia, based on Phase 3 CORE and CORE2 results.

Original source language: PR NewswireOpen original release →

Add your company to Business Communicator

We monitor business sources and connect attention with companies, profiles and services available in Business Communicator.

Create a free company profile Explore businesses on Business Maps →

Create a free company profile →

Explore insights

Business insights →

Global Markets News Trade Regulation News Business Technology News Fintech for Business: Payments & Banking News Supply Chain News Central Bank Policy News

Related business signals

Business · 10/22/2026

The American beauty retailer Miss A, a one-trillion dollar entrepreneur recognized... $1 billion in revenue in 2030 and 550 stores challenged.

U.S.-based consumer goods specialist investor VMG Partners Investment Attraction...First store opening in 10 years has grown to approximately 100 stores across the United States, South Korea Seoul, October 22, 2026 — The Miss A beauty lifestyle brand launched in the United Kingdom attracted strategic investment from global consumer goods expert investor VM G Partners and was recognized for its entrepreneurial approach of 1 trillion dollars. In 2016, in the U. S. ...

Read summary →

Business · 10/21/2026

Underlining the need for funding to reinforce radiation science, the Fourth Committee approves a draft praising its valuable inputs

Comparing the rigorous, evidence-based work of the United Nations Scientific Committee on the Effects of Atomic Radiation, the Fourth Committee (Special Political and Decolonization) today approved without a vote a r...

Read summary →

Business · 10/21/2026

The Commission shall adopt delegated acts in accordance with Article 21 of Regulation (EC) No 1907/2006 and with the opinion of the European Parliament and of the Council.

The Commission shall adopt delegated acts in accordance with Article 21 of Regulation (EC) No 1290/2009.

Read summary →

Business · 10/21/2026

Celebrity, Genesis and the Fall release based on Genesis: more evidence, deeper insights, broader access to investigations

Investigators, using AI as a tool for agency, assessed that evidence-based discovery performance against manual review has improved significantly... In the fall of 2026, release, device and operating system access support expanded Virginia Tysons Corner and Israel Petatikeva, October 21, 2026 — Celebrity: CLBT, a global leader in AI-based digital research and information analytics solutions for public and private sectors, announced its announcement on Oct. 21, 2026.

Read summary →